Latest filing published 27 Dec 2019 for Dicerna Pharmaceuticals Inc, €52k.
Ralf Rosskamp has filed trades across 2 companies (mainly through SEC (Form 4)), most often in KOS Pharmaceuticals Inc and Dicerna Pharmaceuticals Inc. We count 6 filings; the first trade dates from 26 January 2006 and the latest from 26 December 2019.
Sales make up the whole of the open-market record (2 sales, €1.2M). Outside the open market, there are 1 share grant and 2 option exercises. Since January 2019: no purchases and 1 sale on the market.
The newest entry dates from 27 December 2019: an option exercise of €52k, in Dicerna Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations